Lynchburg Journal of Medical Science
Dr. Tom Colletti, DHSc, PA-C, DFAAPA
Purpose: The purpose of this article is to review the current treatment options of androgenetic alopecia and to explore the risk and potential benefits of oral Minoxidil therapy.
Method: A PubMed literature search was conducted with search terms androgenetic alopecia, alopecia, minoxidil, oral minoxidil risks. A total of 10 pertinent articles were retrieved and served as the basis for this clinical review.
Results: Despite evidence of safety profile of oral minoxidil, only topical formulation along with oral finasteride has been stamped as the mainstay of treatment.
Conclusion: Oral minoxidil has a safety profile worth considering when prescribed at a lower dose than prescribed for refractory hypertension when treating patients with androgenetic alopecia. Current therapy consisting of topical minoxidil can be cumbersome for patients to comply with twice daily as currently recommended.
Keywords: Minoxidil, finasteride, alopecia, androgenetic alopecia.
Ingram LD. Oral Minoxidil for Androgenetic Alopecia. Lynchburg Journal of Medical Science. 2022; 4(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.